Stay updated on DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe revision tag v3.5.4 was added and the previous v3.5.3 was removed. This reflects a backend/content update to the page's revision history.SummaryDifference0.0%

- Check27 days agoChange DetectedBranding elements referencing Mayo Clinic (the Mayo Clinic web site, Mayo Clinic, and the 'Helpful Links Provided by Mayo Clinic' blocks) were removed from the page.SummaryDifference0.1%

- Check41 days agoChange DetectedThe page’s footer revision/version indicator was incremented from **v3.5.2** to **v3.5.3**, reflecting a site/record interface update rather than a change to the clinical trial details.SummaryDifference0.0%

- Check48 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check77 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check84 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. No substantive content changes are visible.SummaryDifference0.0%

Stay in the know with updates to DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial page.